People who get roughly 48 more minutes of REM sleep per night show a lower risk of 83 diseases, including Parkinson’s syndrome, dementia and heart failure, according to a study from researchers at Peking University published in PLOS Medicine.
The finding comes from nearly 100,000 adults tracked with wrist sensors and followed for about nine years.
Longer REM sleep — the dream-rich phase when the brain is almost as active as when awake — was associated with an 80 percent lower risk of Parkinson syndrome, a 52 percent lower risk of multiple sclerosis, a 46 percent lower risk of dementia and a 26 percent lower risk of heart failure, WELT reported, according to DIE WELT.
Why does this matter to patients? Because most sleep advice stops at duration. This study suggests that what happens during sleep — how long the brain spends consolidating emotion, memory and motor learning — may carry independent weight for neurological and cardiovascular health.
oe24.at, which also covered the study, added detail on scale and method: researchers analyzed data from 95,559 UK Biobank participants who wore an accelerometer for seven days. An algorithm derived sleep stages — REM, deep sleep, total duration and nighttime awakenings. Health outcomes were then tracked for a median of 8.9 years against 1,049 different conditions.

In Plain English: The Clinical Takeaway
- REM sleep is the dream phase, usually 20 to 25 percent of an adult night, and it mostly happens in the second half of sleep.
- People in this study with more REM sleep developed 83 of the tracked diseases less often — but the study shows a link, not proof that more REM sleep prevents illness.
- The “sweet spot” for total sleep in most disease categories was predominantly between six and eight hours per night; less than six and more than eight hours carried higher risks.
REM Sleep: What Happens in the Dream Phase
REM stands for rapid eye movement: the eyes dart back and forth under closed lids while the brain’s activity resembles waking, but the muscles stay largely relaxed. The brain processes emotions and information, consolidates motor skills such as playing an instrument, and regulates the cardiovascular and nervous systems, WELT explained in its report.
REM phases occur several times a night and grow longer toward morning — which is one reason why cutting sleep short disproportionately trims REM time. oe24.at said that more deep sleep was separately linked to a lower risk of seven conditions, including type 2 diabetes, depression, sleep apnea and Parkinson’s.
The Numbers Behind the Findings
The risk reductions WELT reported are associations drawn from observational data. Here is how the key figures compare:
| Outcome | Finding |
|---|---|
| Parkinson syndrome risk | 80% lower with longer REM sleep |
| Multiple sclerosis risk | 52% lower |
| Dementia risk | 46% lower |
| Heart failure risk | 26% lower |
oe24.at framed the overall picture slightly differently from WELT: it reported that differences in sleep were associated with 156 diseases in total, with REM duration tied to lower risk for 83 of them. It also flagged that people sleeping fewer than five hours showed the most unfavorable associations.
What This Means for Patients and Health Systems
For patients, the findings add to discussions about sleep as a cardiovascular and neurological risk factor. For readers in Europe and the United States, no regulator treats sleep architecture as a diagnostic target yet; the practical takeaway for now is preventive, not prescriptive.
The six-to-eight-hour range also gives clinicians a defensible answer to a common question. WELT reported that sleeping more than eight hours raised depression risk by 60 percent, while sleeping under six hours raised heart failure risk by 30 percent — a reminder that both sleep debt and excess carry measurable associations.
Contraindications & When to Consult a Doctor
No treatment is involved here, so there are no contraindications in the pharmacological sense. But readers should seek medical evaluation if they notice persistent difficulties. Self-adjusting sleep duration upward is not a disease-prevention strategy — the study’s authors, as reported by both outlets, established association, not therapeutic benefit.
Where the Research Goes Next
The open question is mechanism: whether REM sleep actively protects the brain and heart, or whether it is a biomarker — a readout of a resilient nervous system. Longitudinal work with objective sleep measurement will be needed to separate the two. Until then, the study’s most defensible message is the one both outlets converged on: sleep quality and architecture, not just hours in bed, belong in the prevention conversation.
References
- PLOS Medicine — Sleep characteristics and disease risk, UK Biobank cohort study
- WELT — “Diese Schlafphase entscheidet über das Risiko für 83 Krankheiten”
- oe24.at — “Diese EINE Schlafphase beeinflusst dein Risiko für 83 Krankheiten”
This article is journalistic reporting and does not constitute medical advice. Consult a qualified physician for questions about your individual sleep health.